Back to Depression And Anxiety
NCT03496675
NCT03496675
Who may be able to join
Who might be able to join this trial:
- You must be living full-time (24 hours a day) in one of the care homes taking part in the study.
- You must have dementia, confirmed by specific memory and thinking tests showing at least mild impairment.
- You must be showing at least some mild symptoms of depression, based on a standard rating scale used by clinicians.
- You must have a formal diagnosis of dementia based on recognised medical guidelines.
- You (or a family member or carer acting on your behalf, if needed) must have agreed to take part in writing.
Who may not be able to join:
- You may not be able to join if you have a diagnosis of schizophrenia or Parkinson's disease.
- You may not be able to join if you have severe hearing difficulties.
- You may not be able to join if you are staying at the care home only on a short-term basis.
- You may not be able to join if you are unable to sit in a chair for the length of the study sessions.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
NORCE Norwegian Research Centre AS
Registry
clinicaltrials_gov
Start date
18 July 2018
Est. completion
29 September 2023
Where this trial is recruiting
🇦🇺 Australia
🇩🇪 Germany
🇳🇱 Netherlands
🇳🇴 Norway
Turkey (Türkiye)
🇬🇧 United Kingdom
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Montgomery-Åsberg Depression Rating Scale (MADRS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.